Gel-like material shows promise as oral insulin pill for diabetes

Dr. Nicholas Peppas

High-resolution version available

Biomedical engineering researchers at The University of Texas at Austin report development of a gel-like material that could help speed the long-awaited arrival of insulin that can be taken in a pill by mouth, rather than with injections. The study appears in the April 14 issue of the American Chemical Society's Biomacromolecules, a monthly journal.

 

In the report, Nicholas A. Peppas, professor of chemical engineering, biomedical engineering and pharmaceutics at the university,  and colleagues point out acid in the stomach destroys insulin, preventing its administration by mouth. Many different research groups worldwide are searching for ways to overcome that obstacle. However, an ideal material for safe, effective oral delivery remains elusive. 

 

The new study describes a promising candidate in the form of a polymer hydrogel that responds to changes in pH levels. This hydrogel has been modified by the addition of wheat germ agglutinin tethers, or anchors, that allow it to interact with the lining of the upper small intestine. In laboratory tests, the gel-like substance containing insulin expands in the acidic environment of the stomach and protects the drug from destruction by stomach acids. Upon exposure to the alkaline environment of the small intestine, the site of insulin absorption, the polymer shrinks and releases insulin. The addition of wheat germ agglutinin, a type of sticky plant sugar, allows the polymer to stick to the small intestine for prolonged periods. This improves the duration of insulin absorption, the researchers say. — from the American Chemical Society


Photo by Beverly Barrett

Biographical Sketch of Dr. Peppas

Background and contact information for Dr. Peppas.

Laboratory Overview

Research projects, student researchers and publications from Dr. Peppas' Laboratory of Biomaterials, Drug Delivery, Bionanotechnology and Molecular Recognition

Biomacromolecules

The American Chemical Society's peer reviewed monthly journal reporting Dr. Peppas' research developing an insulin pill for diabetes.

American Chemical Society Pressroom

News releases on the latest research publications and press contacts for the society.